Tumor suppressor proteins as regulators of cell differentiation

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4282-4287

  Li, Zhan Rong ^a   Hromchak, Rosemary ^a   Mudipalli, Anuradha ^a   Bloch, Alexander ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA SYNTHESIS; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOKINES; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENES, TUMOR SUPPRESSOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEUKEMIA, MYELOCYTIC, ACUTE; MACROPHAGES; MONOCYTES; PHOSPHOPROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEINS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P130; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032189684     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bos, T. J. Oncogenes and cell growth. Adv. Exp. Med. Biol., 321: 45-49, 1992.
2. Levine, A. J. The tumor suppressor genes. Annu. Rev. Biochem., 62: 623-651, 1993.
3. Bergh, G., Ehinger, M., Olofsson, T., Baldetorp, B., Johnsson, E., Brycke, H., Lindgren, G., Olsson, I., and Gullberg, U. Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation. Blood, 89: 2938-2950, 1997.
4. Zhu, Y-M., Bradbury, D. A., and Russell, N. H. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br. J. Cancer. 69: 468-472, 1994.
5. Baldi, A., Boccia, V., Claudio, P. P., De Luca, A., and Giordano, A. Genomic structure of the human retinoblastoma-related Rb2/p130 gene. Proc. atl. Acad. Sci. USA, 93: 4629-4632, 1996.
6. Shivakumar, C. V., Brown, D. R., Deb, S., and Deb, S. P. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol. Cell. Biol., 15: 6785-6793, 1995.
7. Johnson, D. G. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene, 11: 1685-1692, 1995.
8. Li, Z-R., Hromchak, R., and Bloch, A. Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. Biochim. Biophys. Acta, 1356: 149-159, 1997.
9. Honma, Y., Honma, C., and Bloch, A. Mechanisms of interaction between antineo-plastic agents and natural differentiation factors in the induction of human leukemic cell maturation. Cancer Res., 46: 6311-6315, 1986.
10. Takeda, K., Minowada. J., and Bloch, A. Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-0-tetradecanoylphorbol-13-acetate. dimethyl sulfoxide, or 1-β-D-arabinofuranosylcytosine. Cancer Res., 42: 5152-5158, 1982.
11. Kelman, Z. PCNA: structure, functions and interactions. Oncogene. 14: 629-640, 1997.
12. Adams, P. D., and Kaelin, W. G., Jr. Transcriptional control by E2F. Semin. Cancer Biol., 6: 99-108, 1995.
13. Krek, W., and DeCaprio, J. A. Cell synchronization. Methods Enzymol., 254: 114-124, 1995.
14. Kastan, M. B., Radin, A. I., Kuerbitz, S. J., Onyekwere, O., Wolkow, C. A., Civin, C. I., Stone, K. D., Woo, T., Ravindranath, Y., and Craig, R. W. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res., 51: 4279-4286, 1991.
15. Mercer, W. E., Shields, M. T., Lin. D., Appella, E., and Ullrich, S. J. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc. Natl. Acad. Sci. USA, 88: 1958-1962, 1991.
16. Jackson, P., Ridgway, P., Rayner, J., Noble, J., and Braithwaite, A. Transcriptional regulation of the PCNA promoter by p53. Biochem. Biophys. Res. Commun., 203: 133-140, 1994.
17. Morris, G. F., Bischoff, J. R., and Mathews, M. B. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc. Natl. Acad. Sci. USA, 93: 895-899, 1996.
18. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, T. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. Waf1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
19. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
20. Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M., and Hurwitz, J. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme. Proc. Natl. Acad. Sci. USA, 91: 8655-8659, 1994.
21. Pan, Z. Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., and Hurwitz, J. Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J. Biol. Chem., 270: 22008-22016. 1995.
22. Strausfeld, U. P., Howell, M., Rempel, R., Mailer, J. L., Hunt, T., and Blow, J. J. Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Curr. Biol., 4: 876-883, 1994.
23. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
24. Chen, J., Jackson, P. K., Kirschner, M. W., and Dutla, A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature (Lond.), 374: 386-395, 1995.
25. Luo, Y., Hurwitz, J., and Massague, J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature (Lond.), 375: 159-161, 1995.
26. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., and Nevins, J. R. The E2F transcription factor is a cellular target for the RB protein. Cell, 65: 1053-1061, 1991.
27. DeGregori, J., Kowalik, T., and Nevins, J. R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol., 15: 4215-4224, 1995.
28. Helin, K., Harlow, E. D., and Fattaey, A. L. I. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol., 13: 6501-6508, 1993.
29. Almog, N., and Rotter, V. Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta, 1333: F1-F27, 1997.
30. Gartel, A. L., Serfas, M. S., and Tyner, A. L. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med., 213: 138-149, 1996.
31. Sidle, A., Palaty, C., Dirks, P., Wiggan, O., Kiess, M., Gill, R. M., Wong, A. K., and Hamel P. A. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit. Rev. Biochem. Mol. Biol., 31: 237-271, 1996.
32. Sachs, L. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc. Natl. Acad. Sci. USA, 77: 6152-6156, 1980.